Fiduciary Trust CO Pliant Therapeutics, Inc. Transaction History
Fiduciary Trust CO
- $7.39 Billion
- Q1 2025
A detailed history of Fiduciary Trust CO transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 11,620 shares of PLRX stock, worth $18,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,620
Previous 11,620
-0.0%
Holding current value
$18,243
Previous $153,000
90.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PLRX
# of Institutions
153Shares Held
62.1MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$9.42 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.48 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.81 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.24 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$4.79 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $76.4M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...